The aim of this study was to estimate and compare the global diagnosed incidence of RCC by region over the next ten years (2019-2029) using a forecast model that incorporates the changing risk of RCC due to population aging, as well as trends in obesity and smoking prevalence.



Biotech's resilient response to 2020

View Now